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Volume 51, Number 11S Abstracts 71SObjectives: The contemporary use of endovascular tech-
niques has progressively limited the role of bypass grafting. As
a result of this paradigm shift and improvement in graft
materials, long-term complications like femoral anastomotic
pseudoaneurysms (FAPs)may be less frequently encountered,
resulting in limited exposure to present-day trainees. The aim
of this study was to investigate changes in the incidence and
outcome of FAPs.
Methods: Over a 20-year period (1987-2006 inclusive),
90 patients (61 males) underwent 120 operations to repair
125 FAPs. All but four of these aneurysms occurred after
aortofemoral grafting. Most patients presented with an iso-
lated pulsatile groin mass; three presented with acute expan-
sion/rupture. Prosthetic interposition graft repair was per-
formed in 97.4% and primary repair in the remainder.
Results: The number of repairs steadily declined over
the study period with the number of repairs performed
during the study’s consecutive quarters being 54, 41, 19
and 6, respectively). Morbidity did not change over the
course of the study and averaged 33%, but mortality did
decrease from 5.3% during the first decade to 0% during
the second decade (p 0.58). Demographics, associated
risk factors and diseases did not influence the above
outcomes. Five-year reoperation-free rate for FAP recur-
rence was 98% for primary repair or PTFE grafting and
85% for Dacron grafting (p  0.057); postoperative
wound complications did not affect these rates. Five and
ten-year patient survival was 55% and 34%, respectively.
Multivariate analysis with Cox regression identified
chronic renal failure and COPD as independent predic-
tors of worse long-term survival (relative risks, 3.6 and 3,
and p values, 0.001 and 0.001, respectively).
Conclusions: Although performed less frequently,
FAP repair is still associated with considerable morbidity.
Compared to Dacron, PTFE interposition graft repair is
associated with a reduced recurrence rate.
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Objectives: Post discharge outcomes are seldom in-
cluded in hospital quality reporting systems. Using the NS-
QIP database we analyzed risk factors related to inpatient vs
outpatient death as well as the time distribution of 30-day
mortality.Methods: We queried the ACS-NSQIP data set from
2005 to 2008 for vascular surgery using CPT and ICD-9
codes. Primary outcomes analyzed were postoperative
in-hospital and post-discharge death. Adjusted odds ra-
tios (OR) for timing and location of death were calcu-
lated by procedure, diagnosis as well as preoperative and
intraoperative risk factors.
Results:Our query resulted in 73, 833 vascular surgery
patients. 25% of deaths occurred after discharge. Overall,
preoperative risk factors predictive of post discharge mor-
tality were creatinine1.2 (OR 1.7), COPD (OR 1.3),
steroid treatment (OR 1.7) and dependent functional sta-
tus (OR 2.7). The timing of in-hospital vs post discharge
death is shown in the figure. Lower extremity amputation
was the only procedure with significantly higher risk of
death after discharge (OR 1.6).
Conclusions: In the 30-day postoperative period after
vascular surgery 1/4th of deaths occurs after discharge; it is
unclear whether this is a result of premature discharge. In-
hospitalmortality as a performancemeasuremay be unreliable
in view of our findings. We identified factors that correspond
to higher risk of post discharge mortality; recognition of
patients with this risk profile, appropriate management of
discharge planning and follow-up care may lead in reduction
of death rate after discharge.
Distribution of 30-day mortality
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